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Background: Rheumatoid arthritis (RA) and periodontitis are both chronic inflammatory 
diseases, which demonstrate similarities in terms of mechanism, histopathology, and 
demography. An association between these conditions has been demonstrated previ-
ously but has been called into question more recently.
Methods: The published databases, such as MEDLINE, EMBASE, and PsycINFO, were 
searched using search terms related to RA and periodontitis. Articles were selected 
if they included data on the number of people with RA diagnosed with periodontitis 
(or periodontal disease parameters) compared to a control comparison group. Review 
articles, case reports, animal model studies, non-English language, and articles with 
unavailable abstracts were excluded. Data were extracted, critically appraised using 
the Downs and Black tool, and a random-effect Mantel–Haenszel meta-analysis was 
performed.
results: Twenty-one papers met the eligibility criteria and provided data for the 
meta-analysis; 17 studies (including a total of 153,492 participants) comparing RA to 
healthy controls and 4 (including a total of 1378 participants) comparing RA to osteo-
arthritis (OA). There was a significantly increased risk of periodontitis in people with 
RA compared to healthy controls (relative risk: 1.13; 95% CI: 1.04, 1.23; p = 0.006; 
N = 153,277) with a significantly raised mean probing depth, risk of bleeding on probing 
(BOP), and absolute value of clinical attachment loss in those with RA. When comparing 
RA and OA, there was no significant difference in the prevalence of periodontitis; how-
ever, the risk of BOP was greater in OA than RA.
conclusion: A significant association between RA and periodontitis is supported by the 
results of our systematic review and meta-analysis of studies comparing RA to healthy 
controls. In our meta-analysis, however, this is not replicated when comparing RA to OA 
controls.
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inTrODUcTiOn
Rheumatoid arthritis (RA) is an autoimmune disease character-
ized by joint inflammation and destruction leading to chronic 
disability, early mortality, systemic complications, and high 
socioeconomic burden on society as a whole (1). It has a preva-
lence of 0.5–1.0% in US populations (2). The exact etiology of RA 
is unknown; however, it is thought to be secondary to an interac-
tion between genetic attributes and environmental exposures, as 
demonstrated by the established association with smoking (3) 
and genetic polymorphisms, including HLA-DRB1 (4).
Auto-antibodies to the Fc portion of immunoglobulin are 
known as rheumatoid factor, and antibodies that form against 
citrullinated proteins are called anti-citrullinated protein anti-
body (ACPA) or anti-cyclic citrullinated peptide (anti-CCP). If 
either of these are present then they confer “seropositivity” that 
is seen in 70–80% of patients (5) and are associated with more 
aggressive disease and with the earlier development of erosions. 
Rheumatoid factor is limited in diagnostic application by low 
specificity; however, ACPA is 95–98% specific (6).
Anti-citrullinated protein antibody has been shown to be 
 present in RA patient sera up to a decade prior to the develop-
ment of the disease (7), although the amount of ACPA and 
inflammatory cytokine levels rises sharply a few months before 
the synovitis presents (8). It is therefore hypothesized that as well 
as citrullination of endogenous proteins, a second inflammatory 
“hit” is required to stimulate the development of RA. Citrullinated 
proteins are also associated with other environmental factors such 
as smoking and pathological conditions, including periodontitis.
Peptidyl arginine deiminase (PAD) causes the post- 
translational modification of arginine to citrulline. It is hypoth-
esized that this citrullination leads to amino acid chains being 
recognized as auto-antigens, which leads to the development of 
auto-antibodies and the subsequent autoimmune damage that 
is the signature for RA. PAD is produced by human cells, for 
example, in the lung; however, it is also produced by the microbe 
Porphyromonas gingivalis (9).
Peptidyl arginine deiminase production by P. gingivalis, an 
anaerobic prokaryote, has been demonstrated in vitro. Due to this 
organism’s role in the development of periodontal disease and the 
association of RA with periodontitis, it has been hypothesized 
that P. gingivalis provides a causal link among periodontal disease, 
citrullination, and RA (10).
Periodontitis is a destructive, infectious-inflammatory condi-
tion affecting the gums. It is characterized by loss of gingival 
attachment between the tooth and the gingivae leading to the 
formation of a periodontal pocket (11). Initially, a biofilm struc-
ture develops, which causes localized inflammation in the form 
of gingivitis. This biofilm is then colonized by anaerobic bacteria 
that cause further inflammation and neutrophillic activation. 
Matrix metalloproteinases are spilled during this inflammatory 
reaction leading to tissue destruction and further exacerbate the 
attachment loss and deepening the periodontal pocket, resulting 
in further anaerobic colonization, soft tissue destruction, alveolar 
bone loss, and, ultimately, tooth loss.
The prevalence of periodontitis varies internationally; however, 
approximately 10–15% of the global adult population are affected by 
the condition (12). Known risk factors include smoking, age, diabe-
tes mellitus (13), educational level (14), and immunological diseases 
(e.g., HIV) (15). Periodontitis, itself is associated with a higher risk 
of stroke, cardiovascular disease (16), and pneumonia (17).
It is divided into two subtypes; aggressive periodontitis and 
chronic periodontitis (CP). CP is the more common form affect-
ing an older population with an indolent disease progression; 
however, aggressive periodontitis is observed in a young popula-
tion, aggregates in families, and leads to rapid tooth loss and the 
need for prostheses (18).
Certain bacteria have been implicated in the development of 
periodontitis, including the “red complex” organisms; P. gingivalis, 
Tannerella forsythia, Treponema denticola, and Aggregatibacter 
actinomycetemcomitans. It is not clear whether there are microbi-
ological differences between the chronic and aggressive subtypes 
of periodontitis (18).
Epidemiological studies have shown a strong association 
between periodontitis and RA (19, 20), though these have been 
hampered by their cross-sectional nature, variability in definition 
of periodontitis and dental endpoints, the extent of oral examina-
tion, and the limited RA information collected.
Shared risk factors, including cigarette smoke, provide pos-
sible confounders; however, an increased risk of periodontitis has 
been demonstrated in a non-smoking RA group (21). In addition, 
it appears that periodontitis responds to RA treatment (22). There 
are also pathological similarities between the two conditions in 
terms of T cell activation, inflammatory cytokine profile and the 
resultant bone destruction and deformity.
The association between the two diseases has recently been 
debated with the relevance of P. gingivalis being called into 
question in a large cohort of pre-RA participants (23). Recently, 
there have been narrative reviews of the literature surrounding 
the association between periodontitis and RA (24–26). However, 
there is no recent systematic review or meta-analysis to re-evaluate 
this association. Our aim was to analyze the association between 
these two conditions in light of all recent evidence in the form of 
a meta-analysis and to include all the most recent published stud-
ies investigating the association of RA and periodontal disease 
worldwide to assess the largest dataset possible for meta-analysis.
MaTerials anD MeThODs
search strategy
We searched the published databases: MEDLINE via OVID, 
EMBASE via OVID, and PsycINFO via OVID. No restrictions 
were placed on date of publication; however, only English lan-
guage articles were selected. Articles were searched for using the 
terms “periodontitis,” “periodontitis.mp,” or “periodontal disease” 
and “rheumatoid arthritis.mp” or “inflammatory arthritis.” All 
papers which presented data on the number of people with RA 
diagnosed with periodontitis or periodontal disease measures/
assessments, compared to a comparison group [such as healthy 
controls or those with osteoarthritis (OA)] were included. Review 
articles, case reports, animal model studies, and those with una-
vailable abstracts were excluded from the analysis. The titles and 
abstracts of each citation were independently reviewed by two 
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authors (Nicholas Rubek Fuggle and Toby O. Smith) and verified 
by a third (Nidhi Sofat). Full texts of all potentially eligible papers 
were independently reviewed by three authors (Nicholas Rubek 
Fuggle, Toby O. Smith, and Nidhi Sofat) with consensus made 
through discussion on final study eligibility.
Data extraction
Data were extracted onto a predefined data extraction table. 
Data extracted included participant number with RA and a 
comparator (e.g., non-RA healthy controls or OA), age, gender, 
ethnic origin, marital status, educational status, smoking history, 
medical history/status (cardiovascular disease, diabetes obesity, 
osteoporosis, antibiotic usage), RA diagnosis, years of disease (if 
RA), measures of disease severity (e.g., rheumatoid factor, CRP, 
ESR, HLA-DRB1), current therapies (e.g., DMARDs, NSAIDS, 
biologics), and periodontitis measure. These included percentage 
with periodontitis, probing depth, plaque index, missing teeth, 
proportion of sites with plaque, bleeding on probing (BOP), and 
clinical attachment loss (CAL). All data were extracted by two 
reviewers independently (Nicholas Rubek Fuggle and Toby O. 
Smith) with any disagreements addressed through discussion.
critical appraisal
All included studies were assessed using the Downs and Black criti-
cal appraisal tool for non-randomized controlled trials (27). This 
is a 27-item critical appraisal tool that assessed study quality (10 
items), external validity (3 items), study bias (7 items), confound-
ing and selection bias (6 items), and power of the study (1 item). 
All papers were independently assessed by one reviewer (Nicholas 
Rubek Fuggle) and verified by a second reviewer (Toby O. Smith).
Data analysis
Study heterogeneity was assessed through visual assessment of 
the data extraction table. As there was homogeneity in participant 
characteristics, periodontal assessment, and study design, a meta-
analysis was undertaken. The primary analysis was to estimate the 
relative risk (RR) of periodontitis for people with RA over people 
without RA, or another non-RA condition such as OA. The 
secondary analyses included estimating the RR or mean differ-
ence (MD) for measures of periodontal disease between patients 
with RA and comparative groups (non-RA or OA). Periodontal 
disease measures included probing depth, plaque index, missing 
teeth, proportion of sites with plaque, BOP, and CAL. A fixed-
effect Mantel–Haenszel meta-analysis was undertaken when 
the inconsistency value (I 2) was 50% or less and Chi2 equated 
p ≥ 0.10. A random-effect Mantel–Haenszel meta-analysis was 
undertaken when I 2 was >50% and Chi2 equated to p <  0.10. 
All analyses were calculated with 95% confidence intervals and 
forest-plots were constructed, and performed on RevMan Version 
5.3 (Copenhagen: The Nordic Cochrane Centre, The Cochrane 
Collaboration, 2014).
resUlTs
search results
A summary of the search results is presented in Figure  1. As 
this illustrates, from a total of 1182 citations identified from the 
search strategy, 67 provisionally met the inclusion criteria. In 
total, 21 papers met the eligibility criteria and provided data for 
the meta-analysis.
characteristics of included studies
The characteristics of the participants from the included studies 
are presented in Table  1. Seventeen studies analyzed data on 
periodontitis in RA compared to non-RA healthy control cohorts 
(21, 28–43). Four studies analyzed data on periodontitis in RA 
compared to OA cohorts (10, 44–46).
In the RA compared to non-RA analysis, a total of 153,492 
participants were analyzed. This consisted of 14,849 people with 
RA, compared to 138,643 non-RA control participants. Mean age 
of the RA cohort was 50.9 (SD: 5.7) years compared to 46.4 years 
(SD: 8.3). In the RA group, duration of RA disease was stated 
in eight studies (10, 21, 29, 33, 34, 36, 37, 46), ranging from 
3.4 months (37) to 16.3 years (34).
In the RA compared to OA analysis, 1378 participants were 
analyzed. This consisted of 654 people with RA were compared 
to 724 individuals with OA. Mean age of the RA cohort was 60.2 
(SD: 2.6) years compared to 62.5 years (SD: 8.3).
critical appraisal
The results of the critical appraisal assessment are presented in 
Table 2.
The evidence-base presented for moderate evidence for 
both the analysis of RA versus non-RA cohorts and RA versus 
OA cohort periodontitis measures. Recurrent strengths to the 
evidence included presenting clear aims and objectives (N = 21; 
100%), presenting outcome data (N = 21; 100%), and participant 
characteristics data clearly (N =  21; 100%), as well as clearly 
presenting information on periodontitis assessment performed 
(N = 21; 100%), using valid and reliable measures of assessment 
in all cases (N = 21; 100%). The included studies for both assess-
ments also analyzed their data with the appropriate statistical 
tests (N = 21; 100%), provided actual probability values (N = 21; 
100%), although only nine studies presented estimates on random 
variability from their data (10, 29, 30, 33, 40–43, 46).
However, recurrent weaknesses in the evidence included 
poorly blinding assessors to their pathological or non-pathologi-
cal group, only masked in four studies (10, 36, 44, 46), recruiting 
cases and controls at the same point in time in only five studies 
(10, 32, 36, 41, 44), whereas only six studies adequately adjusted 
their analyses for important confounders such as smoking and 
alcohol history and antibiotic usage (10, 21, 30, 35, 39, 44). Only 
10 papers recruited cohorts that consisted of 50 participants or 
more per group (10, 21, 30, 35, 36, 39, 40, 42–44). Finally, no stud-
ies adjusted their analysis based on different lengths of follow-up 
or duration between cases and control.
Meta-analysis: risk ratio of Periodontitis 
in ra versus non-ra Participants
The results of the meta-analyses are presented in Table 3.
The assessment of episodes of periodontitis was assessed in 
14 studies. There was a statistically significantly greater risk of 
periodontitis for people with RA compared to health comparable 
FigUre 1 | PrisMa flow-chart depicting the results of the search strategy.
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cohorts. Those with RA had a 13% greater risk of periodontitis 
compared to the non-RA cohort, ranging from 4 to 23% (RR: 
1.13; 95% CI: 1.04, 1.23; p = 0.006; N = 153,277; Figure 2).
The 17 studies were included in the whole RA analysis but 
not all assessed periodontitis risk (as a whole), with 7 present-
ing data on specific features of periodontitis, including probing 
depth, plaque index, BOP, etc., which were reported in Table 3. 
This accounts for the difference in Figure 2 and the whole dataset 
that is presented in the characteristics of included studies. On 
secondary analysis, there was no statistically significant differ-
ence in the risk of the probing depth >5 mm (RR: 4.93; 95% CI: 
0.84, 28.95) or plaque index as assessed through the frequency of 
participants >0.6 (RR: 1.23; 95% CI: 0.81, 1.88) or plaque index 
value (MD: 2.27; 95% CI: −0.16, 4.70) between the RA cohort 
than non-RA cohort.
There was a significantly greater risk in the RA cohort of the 
frequency of any BOP in the RA cohort compared to the non-RA 
cohort (RR: 2.65; 95% CI: 1.00, 7.02; p = 0.05), gingivitis index 
(MD: 0.30; 95% CI: 0.20, 0.41), mean loss of teeth (MD: 2.46; 
95% CI: 0.30, 4.63), and periodontal bone loss (RR: 2.05; 95% CI: 
1.40, 2.98). There was also a significant difference between the 
RA and non-RA cohort for probing depth with the RA cohort 
demonstrating a 0.69-mm greater probing depth than the non-
RA cohort (MD: 0.69; 95% CI: 0.26, 1.12).
Although there was no statistically significant difference between 
the cohorts for the assessment of the frequency of CAL (RR: 3.63; 
TaBle 1 | characteristics of included studies.
reference N  
(ra/comparison)
comparison group Mean age (ra/
comparison)
gender  
(% female)
current smokers  
(ra/comparison %)
ex-smokers  
(ra/comparison %)
Years of ra 
disease
ra rheumatoid 
factor + (%)
Das28
Abou-Raya et al. (36) 50/50 Non-RA control 52.5/52 80/80 N/S N/S 13.5 86 4.9
Bıyıkoğlu et al. (38) 30/15 Non-RA control 52.7/46.6 N/S N/S N/S N/S N/S N/S
Bıyıkoğlu et al. (13) 23/17 Non-RA control 52.7/40.7 78/47 22/35 N/S 16.3 26 N/S
Chen et al. (30) 13,779/137,790 Non-RA control 52.6/52.4 77/77 N/S N/S N/S N/S N/S
Coburn et al. (44) 287/330 OA 57/58 72/78 15/8 31/23 N/S N/S N/S
de Smit et al. (33) 95/44 Non-RA control 56/34 68/57 23/27 40/43 7.4 53 2.4
Dissick et al. (46) 69/35 OA 62/58 17/14 20/17 45/29 14 56 N/S
Esen et al. (41) 20/20 Non-RA control 40.1/44.4 80/95 N/S 10/5 N/S N/S 3.2
Janssen et al. (31) 86/36 Non-RA control 57/26 56/59 60/42 17/36 N/S 74 2.2
Joseph et al. (39) 100/112 Non-RA control 46.5/45.9 76/86 N/S N/S N/S N/S N/S
Lee et al. (35) 248/85 Non-RA control 60.1/59.1 88/87 2/5 4/5 N/S N/S N/S
Reichert et al. (28) 42/114 Non-RA control 56.1/53.8 22/26 6/3 5/4 N/S N/S N/S
Mercado et al. (42) 65/65 Non-RA control 56.4 (total) 75 (total) 7/7 N/S N/S N/S N/S
Mikuls et al. (10) 287/330 OA 59/59 37/40 19/11 43/35 12.6 77 3.2
Mirrielees et al. (32) 35/35 Non-RA control 46.8/43 77/74 11/0 N/S N/S N/S N/S
Pischon et al. (40) 57/52 Non-RA control 52.1/52.1 86/83 21/19 39/21 N/S N/S N/S
Potikuri et al. (21) 91/93 Non-RA control 43.9/41.8 84/74 N/S N/S 2.0 63 7.2
Scher et al. (37) 31/18 Non-RA control 42.2/42.2 68/65 16/6 16/16 3.4 months 92 5.8
Susanto et al. (43) 75/75 Non-RA control 46.5/46.9 80/80 7/7 N/S N/S N/S N/S
Témoin et al. (45) 11/25 OA 62.6/75.0 N/S N/S N/S N/S N/S N/S
Wolff et al. (29) 22/22 Non-RA control 51.7/51.9 68/68 3/3 10/10 5.9 months 37 4.6
DAS28, disease activity score 28; N/S, not stated; OA, osteoarthritis; RA, rheumatoid arthritis.
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TaBle 2 | Downs and Black critical appraisal results.
reference Downs and Black appraisal criteria
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27
Abou-Raya et al. (36) ✓ ✓ ✓ ✓ X ✓ X N N ✓ X X X N ✓ N X ✓ N ✓ ✓ ✓ N N X N ✓
Bıyıkoğlu et al. (38) ✓ ✓ ✓ ✓ ✓ ✓ X N N ✓ ✓ ✓ ✓ N X N X ✓ N ✓ X X N N X N X
Bıyıkoğlu et al. (34) ✓ ✓ ✓ ✓ ✓ ✓ X N N ✓ ✓ ✓ ✓ N X N X ✓ N ✓ X X N N X N X
Chen et al. (30) ✓ ✓ ✓ ✓ ✓ ✓ ✓ N N ✓ ✓ ✓ ✓ N X N X ✓ N ✓ X X N N ✓ N ✓
Coburn et al. (44) ✓ ✓ ✓ ✓ ✓ ✓ X N N ✓ ✓ ✓ ✓ N ✓ N X ✓ N ✓ ✓ ✓ N N ✓ N ✓
de Smit et al. (33) ✓ ✓ ✓ ✓ ✓ ✓ ✓ N N ✓ ✓ ✓ ✓ N X N X ✓ N ✓ X X N N X ✓ X
Dissick et al. (46) ✓ ✓ ✓ ✓ ✓ ✓ ✓ N N ✓ ✓ ✓ ✓ N ✓ N X ✓ N ✓ ✓ X N N X N X
Esen et al. (41) ✓ ✓ ✓ ✓ ✓ ✓ ✓ N N ✓ ✓ ✓ ✓ N X N X ✓ N ✓ ✓ ✓ N N X N X
Janssen et al. (31) ✓ ✓ ✓ ✓ ✓ ✓ X N N ✓ ✓ X X N X N X ✓ N ✓ X X N N X N X
Joseph et al. (39) ✓ ✓ ✓ ✓ ✓ ✓ X N N ✓ ✓ X ✓ N X N X ✓ N ✓ X X N N ✓ N ✓
Lee et al. (35) ✓ ✓ ✓ ✓ ✓ ✓ X N N ✓ X X X N X N X ✓ N ✓ X X N N ✓ N ✓
Mercado et al. (42) ✓ ✓ ✓ ✓ ✓ ✓ ✓ N N ✓ ✓ ✓ ✓ N X N X ✓ N ✓ ✓ X N N X N X
Mikuls et al. (10) ✓ ✓ ✓ ✓ ✓ ✓ ✓ N N ✓ ✓ ✓ ✓ N ✓ N X ✓ N ✓ ✓ ✓ N N ✓ N ✓
Mirrielees et al. (32) ✓ ✓ ✓ ✓ ✓ ✓ X N N ✓ ✓ ✓ ✓ N X N X ✓ N ✓ ✓ ✓ N N X N X
Reichert et al. (28) ✓ ✓ ✓ ✓ X ✓ X N N ✓ X  X ✓ N X N X ✓ N ✓ X X N N X N ✓
Pischon et al. (40) ✓ ✓ ✓ ✓ ✓ ✓ ✓ N N ✓ ✓ ✓ ✓ N X N X ✓ N ✓ X X N N X N ✓
Potikuri et al. (21) ✓ ✓ ✓ ✓ ✓ ✓ X N N ✓ X X X N X N X ✓ N ✓ X X N N ✓ N ✓
Scher et al. (37) ✓ ✓ ✓ ✓ X ✓ X N N ✓ ✓ ✓ ✓ N X N X ✓ N ✓ X X N N X N X
Susanto et al. (43) ✓ ✓ ✓ ✓ ✓ ✓ ✓ N N ✓ ✓ ✓ ✓ N X N X ✓ N ✓ ✓ X N N X N ✓
Témoin et al. (45) ✓ ✓ ✓ ✓ X ✓ X N N ✓ X X X N X N X ✓ N ✓ X X N N X N X
Wolff et al. (29) ✓ ✓ ✓ ✓ ✓ ✓ ✓ N N ✓ ✓ ✓ ✓ N X N X ✓ N ✓ X X N N X N X
 ✓, satisfied; X, not satisfied; N, not applicable.
 1. Hypotheses/aims/objectives clearly stated.
 2. Main outcome measures clearly described.
 3. Characteristics of patients/subjects clearly described.
 4. Interventions of interest clearly described.
 5. Distribution of principal confounders in each group clearly described.
 6. Main findings clearly described.
 7. Estimates of random variability in the data provided.
 8. Important adverse events reported.
 9. Characteristics of patients lost to follow-up described.
10. Actual probability values reported.
11. Participants approached representative of entire population.
12. Participants recruited representative of entire population.
13. Staff, places, and facilities representative of majority of population.
14. Blinding of study subjects.
15. Blinding of assessors.
16. Data based on data-dredging clearly stated.
17. Adjustment of different length of follow-up or duration between case and control.
18. Appropriate statistical tests used.
19. Compliance to intervention reliable.
20. Main outcome measure reliable and valid.
21. Intervention groups or case–controls recruited from same population.
22. Intervention groups or case–controls recruited at the same time.
23. Study subjects randomized to the interventions.
24. Was concealed randomization to allocation undertaken.
25. Adequate adjustment made in the analysis of confounders.
26. Patient losses accounted for.
27. Sufficiently powered cohort size.
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95% CI: 0.40; 32.88), the RA cohort presented with greater CAL 
when assessed as an absolute value (MD: 0.99; 95% CI: 0.38, 1.61).
Meta-analysis: risk ratio of Periodontitis 
in ra versus Oa Participants
There was no statistically significant difference in risk of peri-
odontitis between people with RA compared to those with OA 
(RR: 1.10; 95% CI: 0.81, 1.49; p = 0.54; N = 1344; Figure 3).
On secondary analysis, there was no statistically significant dif-
ference in the risk of the probing depth >5 mm in the RA cohort 
compared to the OA cohort (RR: 1.11; 95% CI: 0.95, 1.31; p = 0.19), 
the frequency of CAL (RR: 1.04; 95% CI: 0.74, 1.48; p = 0.81), or 
in the mean loss of teeth between those with RA compared to OA 
(MD: 0.10; 95% CI: −0.62, 0.42). There was, however, a significant 
difference in the risk of BOP, where the OA cohort presented with 
an 8% greater risk of exhibiting this feature of periodontitis com-
pared to the RA cohort (RR: 0.92; 95% CI: 0.88, 0.97; p = 0.002).
DiscUssiOn
We performed a meta-analysis to investigate the relation-
ship between periodontitis and RA, finding that there was a 
FigUre 2 | Forest-plot representing risk ratio of periodontitis between patients with ra and healthy control comparisons.
TaBle 3 | results from the meta-analyses.
Outcome relative risk  
(95% ci)
p-Value N statistical heterogeneity 
(I 2; chi2)
ra versus non-ra
Periodontitis (frequency) 1.13 (1.04, 1.23) 0.006 153,277 95%; <0.001
Probing depth (frequency >5 mm) 4.93 (0.84, 28.95) 0.08 339 85%; 0.001
Probing depth (mm) 0.69 (0.26, 1.12)a 0.002 1072 98%; <0.001
Plaque index (frequency >0.6) 1.23 (0.81, 1.88) 0.33 379 65%; 0.04
Plaque index (mean) 2.27 (−0.16, 4.70)a 0.07 522 99%; <0.001
Any bleeding on probing (frequency) 2.65 (1.00, 7.02) 0.05 792 74%; <0.001
Clinical attachment loss (frequency) 3.63 (0.40, 32.88) 0.25 170 91%; <0.001
Clinical attachment loss (mm) 0.99 (0.38, 1.61)a 0.002 958 97%; <0.001
Gingivitis Index (mean) 0.30 (0.20, 0.41)a <0.001 654 72%; 0.03
Loss teeth (mean) 2.46 (0.30, 4.63)a 0.03 495 80%; 0.002
Periodontal bone loss (frequency moderate-to-severe) 2.05 (1.40, 2.98) <0.001 130 N/E
ra versus Oa
Periodontitis (frequency) 1.10 (0.81, 1.49) 0.54 1344 70%; 0.02
Probing depth (frequency >5 mm) 1.11 (0.95, 1.31) 0.19 617 N/E
Any bleeding on probing (frequency) 0.92 (0.88, 0.97) 0.002 617 N/E
Clinical attachment loss (frequency) 1.04 (0.74, 1.48) 0.81 617 N/E
Loss teeth (mean) −0.10 (−0.62, 0.42)a 0.71 617 N/E
aMean difference analysis as opposed to relative risk analysis.
CI, confidence intervals; I 2, inconsistency value; N, number of participants; N/E, not estimatable; OA, osteoarthritis; RA, rheumatoid arthritis.
March 2016 | Volume 7 | Article 807
Fuggle et al. Meta-Analysis of Rheumatoid Arthritis and Periodontitis
Frontiers in Immunology | www.frontiersin.org
significantly greater risk of periodontitis in people with RA when 
compared to healthy (non-RA) controls (RR 1.13, 95% CI: 1.04, 
1.23; p = 0.006). This finding was not demonstrated when com-
paring the risk of periodontitis in RA and OA controls.
There was no significant difference in probing depths >5 mm 
in RA compared to healthy controls; however, there was a 0.69-
mm greater probing depth in RA. Although the frequency of CAL 
did not significantly differ between RA and controls; however, the 
absolute value of CAL demonstrated a MD of 0.99 (95% CI: 0.38, 
1.61). There was an increased risk of BOP in RA compared to 
healthy controls (2.65, 95% CI: 1.00, 7.02; p = 0.05) but, interest-
ingly, a reduced risk compared to OA patients (0.92, 95% CI: 0.88, 
0.97; p = 0.002).
In terms of oral hygiene parameters, gingival index was signifi-
cantly higher in RA compared to healthy controls; however, this 
finding was not replicated in plaque index, another parameter of 
oral hygiene. There was a significantly higher mean loss of teeth in 
RA compared to controls (MD: 2.46, 95% CI: 0.30, 4.63).
Our primary finding that there is an increased risk of peri-
odontitis in patients with RA compared to healthy controls is in 
consort with the findings of recent narrative reviews, but our study 
is the first meta-analysis of its kind interrogating this question. In 
2015, Araújo and colleagues published a critical appraisal of stud-
ies investigating the relationship between RA and periodontitis 
(47). Papers published since 2012 were selected including eight 
epidemiological studies, four periodontal intervention studies, 
FigUre 3 | Forest-plot representing risk ratio of periodontitis between patients with ra and Oa participants.
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and five investigating the role of inflammatory mediators in both 
diseases. They found that 21 studies demonstrated an association 
though statistical analysis and 3 studies demonstrated an associa-
tion through descriptive analysis between RA and periodontitis 
(47). We found an association between RA and periodontitis in 
our meta-analysis of papers published until October 2015 across 
an international dataset.
With respect to underlying pathophysiology, CP and RA share 
many pathological features. These include a number of factors, 
including oxygen metabolism (41), other shared mechanisms, 
including active and quiescent inflammatory phases, with the 
release of several mediators that are common to both conditions, 
including interleukin  1-beta and prostaglandin E2 (48–50). 
Similarly, collagenase is a metalloproteinase that specifically 
degrades collagen. It is not only detected at elevated levels in RA 
synovial fluid and in the circulation in subjects with RA but also 
found in gingival crevicular fluid (GCF) and gingival tissue (48). 
Collagenase activity is higher in GCF from subjects with peri-
odontitis than healthy controls (49). Kobayashi et al. (50) reported 
that the disease activity of RA correlates with serum levels of IL-6, 
TNF alpha, and CRP, and the higher cytokine levels may influ-
ence BOP depth in RA in patients with moderate to high disease 
activity. Citrullination of auto-antigens is one of the hallmarks 
of RA and antibodies to cyclic citrullinated peptides are associ-
ated with more aggressive and erosive rheumatoid disease. The 
main human enzyme causing citrullination is peptidylarginine 
deiminase (PAD). The only known bacterial enzyme causing cit-
rullination is PPAD, produced by P. gingivalis. P gingivalis forms 
part of the red complex of organisms implicated in periodontitis. 
Several studies worldwide have been conducted to investigate the 
presence of anti-P. gingivalis antibodies. Okada et al. (51) showed 
significantly higher levels of anti-Pg and anti-CCP antibodies 
than controls (p = 0.04 and p < 0.0001). In their study, the inves-
tigators also showed a significant association of anti-Pg responses 
with RA, after adjustment for age, sex, and smoking (p = 0.005 
and p = 0.02), suggesting that serum levels of anti-Pg antibodies 
are associated with RA and might affect serum levels of RF and 
periodontal condition in patients with RA.
study limitations
The analysis of periodontitis is complicated by differences in the defini-
tion of the disease, with some studies defining “mild/moderate/severe” 
periodontitis (31, 33, 35, 44, 52), others using clinical parameters of 
periodontitis, including probing depth (10, 29, 38, 40, 53, 54) and 
CAL (55). In none of the papers, a division of periodontitis into the 
aggressive and chronic phenotypes of the disease a fact that may be 
relevant as RA is more classically related to CP was found. Therefore, 
we recognize that our study has limitations, thus the results should be 
interpreted with caution.
Heterogeneity of disease is also an issue when considering the 
RA populations studied with marked variation in the range of 
disease duration from a mean of 3.4 months (37) to 16.3 years 
(34). The temporal relationship between RA and periodontitis is 
yet to be established and one of the difficulties in comparing the 
outcomes of these two studies would be the markedly different 
disease populations. The difference in disease activity was most 
commonly assessed by DAS28 score and varied from a mean 
score of 2.2 (31) to 7.21 (21), again, representing phenotypically 
distinct disease that may affect the relationship with periodontal 
inflammation. However, in terms of meta-analysis, it is useful to 
have the whole range of the disease spectrum represented.
Treatment regimens were often not stated; however, those 
that were did vary in terms of the use of DMARDs varying from 
0% in the new-onset arthritis patients in Scher et al.’s study (37) 
and 79% of patients taking at least one DMARD in the study of 
Janssen and colleagues (31). There is also variation with regard 
to the type of DMARD used with 74% of participants taking 
hydroxychloroquine (56), 71% on methotrexate (31) and over 
half on biological therapy (32). These variations can be accounted 
for by geographical location and the variation in treatment vogue 
over the time span of the papers sampled for the meta-analysis. 
Variation in therapeutics may be relevant as it is possible that RA 
DMARD therapy could also attenuate periodontitis and thus a 
seeming reduction in association.
Smoking is a confounder for periodontitis (57) and RA (58) 
possibly due to the role of cigarette smoke in citrullination and 
the production of reactive oxygen species. As such it is perhaps 
limiting, in terms of adjustment for confounding, that seven of 
the studies selected did not comment on the current smoking 
status of participants.
The studies included in our analysis were not investigating 
cause and effect but rather establishing the point prevalence of 
periodontitis and RA. Further longitudinal trials are required to 
establish the temporal nature of this association.
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cOnclUsiOn
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studies are required in future to elucidate the mechanism of this 
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